Experimental study on efficacy of bone marrow mesenchymal stem cell modified by plasmid pIRESneo-EGFP-BDNF in treatment of rats with Parkinson’s disease
Objective:To investigate efficacy of bone marrow mesenchymal stem cells(MSCs) modified by plasmid pIRESneo-EGFP-BDNF in treatment of rats with Parkinson’s disease(PD). Methods:pIRESneo-EGFP-BDNF plasmid was established by reconstructing pEGFP(N1)-BDNF plasmid and bone marrow MSCs was transfected by electroproation. PD rat models were set up by 6-OHDA and then divided into four groups randonly:sham group,PD group,MSCs group and brain-derived neurotrophic factor(BDNF) group. Rotating behaviors of rats were induced by intraperitoneal injection of Apomorphine at 2,4,8 weeks after bone marrow MSCs transplantation or MSCs modification of plasmid pIRESneo-EGFP-BDNF through cerebral lateral ventricle. BDNF protein and tyrosine hydroxylase(TH) protein in mesencephalic nigra were measured by Western blot. Results:Plasmids pIRESneo-EGFP-BDNF were constructed successfully,which was identified by double digestion. Rotation numbers were significantly decreased in MSCs group and BDNF group than in PD group at 2,4,8 weeks after the transplantation(P<0.05),with more evident improvement in BDNF group than in MSCs group(P<0.05). Levels of BDNF protein and TH protein in nigra at 8 weeks after PD model being intervened by cell transplantation were increased significantly in BDNF group than in MSCs group and PD group. Conclusions:Transplantation of pIRESneo-EGFP-BDNF modified MSCs through cerebral lateral ventricle can improve PD rats’ behavior and increase BDNF and TH protein levels.